D-0477-2024 Class II

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0477-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Mar 25, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications Affected quantity: 2784 bottles.

Recall details

Product Type
Drugs
Report Date
May 8, 2024
Initiation Date
Mar 25, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2784 bottles

Product description

Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

US Nationwide.

Code information

Lot #: BJ01922A, exp. date 03/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0477-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0477-2024. Report a data issue: hello@regdatalab.com.